Fresenius Medical Care | FME - Assets


Fresenius Medical Care reported EUR31.45B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Akzo Nobel EUR 16.02B 114M Sep/2026
Alcon AG USD 31.1B 521M Jun/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Beiersdorf EUR 13.32B 560M Jun/2026
DaVita Healthcare Partners USD 17.82B 107.02M Sep/2026
Demant DKK 40.03B 951M Jun/2026
E.ON EUR 115.44B 1.78B Jun/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
Genmab DKK 12.52B 139M Jun/2026
Getinge SEK 57.37B 6.55B Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GN Store Nord DKK 30.31B 762M Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Novartis USD 117.15B 4.88B Sep/2026
Philips EUR 28.03B 1.33B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
RWE EUR 115.73B 1.04B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
SAP EUR 76.34B 727M Sep/2026
Smith & Nephew USD 11.01B 321M Jun/2026